ApoB Test: Better for Cholesterol Treatment

By Catamist AI AI summary

Summarized by Catamist’s AI from other outlets’ reporting and checked for neutrality. Original sources are linked below.

A groundbreaking study reveals that the apoB blood test is significantly more effective and accurate than traditional LDL cholesterol testing for identifying individuals at high risk of cardiovascular events. This superior method, which directly measures harmful cholesterol particles, promises to prevent more heart attacks and strokes while also being cost-efficient, despite not yet being widely adopted in routine care.

A recent study indicates that the apoB blood test, which measures harmful cholesterol particles, is more effective than traditional LDL cholesterol testing for identifying individuals who require more aggressive treatment.
Researchers believe this improved testing could lead to the prevention of more heart attacks and cardiovascular events.
According to Medical News Today, the study, published in JAMA, suggests that ApoB provides a more accurate assessment of cardiovascular risk than traditional markers like LDL or non-HDL cholesterol.
Northwestern Medicine News Center highlighted that the study found ApoB testing to be not only more effective but also cost-efficient for the U.S. healthcare system in guiding cholesterol-lowering therapy.
As reported by ScienceDaily, lead author Ciaran Kohli-Lynch noted that using ApoB to guide treatment would prevent more heart attacks and strokes than current practices, offering good value for healthcare payers.
Harvard Health explains that ApoB is a better indicator of heart disease risk because it measures the total number of atherogenic particles, unlike LDL cholesterol which is an estimate.
Despite growing evidence, ApoB testing is not yet widely used in routine care, although new guidelines are encouraging earlier and more aggressive cholesterol-lowering treatment for many individuals.